Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,430 public trials 1,038 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation

NCT04253314

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Moscow State budget healthcare /ID# 218569 Moscow, Russia
  • Saratov State Medical University n.a. V.I. Razumovskiy /ID# 226059 Saratov, Saratov Oblast, Russia
  • Hematology department State budgetary health care institution Volgograd region /ID# 229813 Volgograd, Volgograd Oblast, Russia
  • Regional Clinical Hospital of Irkutsk /ID# 218570 Irkutsk, Russia
View Trial Details
Completed

Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of ASP2215 in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT02181660

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Site JP00002 Aichi, Japan
  • Site JP00003 Fukuoka, Japan
  • Site JP00001 Gunma, Japan
  • Site JP00004 Tokyo, Japan
View Trial Details
Completed

A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT02236013

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Site US10003 Los Angeles, California, United States
  • Site US10013 New Haven, Connecticut, United States
  • Site US10004 Chicago, Illinois, United States
  • Site US10009 Westwood, Kansas, United States
View Trial Details
Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies

NCT02175433

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Site US0006 Duarte, California, United States
  • Site US0002 Stanford, California, United States
  • Site US0004 Fairway, Kansas, United States
  • Site US0001 New York, United States
View Trial Details
Completed

Evaluation of CPX-351 Monotherapy in Acute Myeloid Leukemia Secondary to Myeloproliferative Neoplasm

NCT04992949

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • AMIENS - CHU Amiens Picardie Amiens, France
  • ANGERS - CHU - Maladies du sang Angers, France
  • AVIGNON - Centre Hospitalier Avignon, France
  • BAYONNE - CH de la Côte Basque - Hématologie Bayonne, France
View all 34 locations
View Trial Details
Completed

Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies

NCT03955783

Conditions
Acute Myeloid Leukemia, Diffuse Large B-cell Lymphoma, Hematologic Diseases, +15 more
Locations
  • Roswell Park Cancer Center Buffalo, New York, United States
  • University Hospitals of Cleveland Cleveland, Ohio, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Completed

Efficacy and Safety of Zanubrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT03206918

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Peking University Peoples Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
View Trial Details

Related conditions